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tor of autograft failure. Among 29 survivors who
underwent an associated mitral valve procedure, 10
patients (35%) experienced autograft failure. Similarly,
of 13 patients with a failed autograft, 10 patients (76%)
had undergone a concomitant mitral valve procedure.
The high incidence of failed mitral valve procedure in
these patients, in itself, is an important cause of mor-
bidity and reoperation and thus limits the usefulness of
the Ross procedure in this subgroup.
Considering the poor results in young patients with
rheumatic etiology (<30 years of age), we have aban-
doned the use of the Ross procedure in this subgroup of
patients. Similarly, coexisting mitral disease, usually
present in the younger subgroup, also disfavors the
Ross procedure.
We thank Mr Rajvir Singh, MSc (Stat), for statistical analy-
sis of the work.
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Commentary
Choudhary and colleagues from the All India Institute of
Medical Sciences documented a high failure rate after aortic
root replacement with pulmonary autografts in young
patients with rheumatic heart valve disease. Of 68 patients
available for follow-up, 13 patients had moderate or severe
aortic insufficiency 1 to 2 years after the operation. In addi-
tion, 5 other patients had echocardiographic evidence of
leaflet thickening, but the valve function was satisfactory at
the time of the study. The diagnosis of rheumatic disease in
the leaflets of the pulmonary autograft was confirmed at
reoperation in 2 patients. On the basis of these findings, the
authors concluded that aortic valve replacment with pul-
monary autograft might be inappropriate for young patients
with rheumatic heart disease.
Other reports have also suggested that the pulmonary valve
may become involved by the rheumatic process when trans-
ferred to the aortic position in young patients with rheumatic
involvement, particularly if they have concomitant mitral valve
disease.1,2 According to Choudhary’s study, antibiotic prophy-
laxis against recurrent streptococcal infection does not seem to
protect the pulmonary autograft from rheumatic disease.
Choudhary and colleagues had excellent results with aortic
root replacement with a pulmonary autograft in a small num-
ber of patients with bicuspid aortic valve disease. On the
basis of their findings, could we then conclude that this pro-
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cedure is bad for young patients with rheumatic aortic valve
disease but good for those patients with bicuspid aortic valve
disease? The answer is yes to the first part of the question and
no to the second for the following reasons: Young patients
with bicuspid aortic valve frequently have a dilated aortic
root as the result of premature degeneration of the media of
the aorta.3 This degenerative process also involves the media
of the pulmonary artery because both the aortic and pul-
monary roots have the same embryologic origin.3 Aortic root
replacement with pulmonary autograft in these patients
exposes the pulmonary root to systemic pressures that may
cause dilatation of the sinuses of Valsalva and sinotubular
junction.3 In the study of Choudhary and colleagues, only 2
patients with rheumatic aortic valve disease had dilatation of
the pulmonary autograft, and the authors did not mention
dilatation in patients with bicuspid aortic valve. In our expe-
rience with this operation on patients with congenital aortic
valve disease, dilatation of the pulmonary autograft is com-
mon when used for aortic root replacement.3 The freedom
from dilatation of 20% or more of the sinotubular junction at
5 years was only 30%. The technique of aortic root inclusion
was protective against dilatation of the sinuses of Valsalva and
sinotubular junction. The freedom from dilatation of the sino-
tubular junction at 5 years was 87% on patients who had the
aortic root inclusion technique. Dilatation of the sinotubular
junction increases the mechanical stress on the leaflets, which
in turn may stretch, develop fenestrations along the commis-
sures, prolapse, and cause aortic insufficiency.
Aortic valve replacement with pulmonary autograft can be
performed with various techniques. Although aortic root
replacement is the simplest and the most reproducible method,
it may not be the most appropriate method because of our
inability to predict which patients will experience the develop-
ment of dilatation of the pulmonary autograft. The techniques
of aortic root inclusion and of subcoronary implantation, albeit
more complicated, are more likely to provide lasting results.3
In the first 131 patients who survived the operation performed
by Donald Ross, 107 patients had the pulmonary autograft
implanted in the subcoronary position, and the overall freedom
from autograft failure was 75% at 20 years.4
Although aortic valve replacement with pulmonary auto-
graft was described more than 3 decades ago, it became pop-
ular only during the past decade. We no longer perform it the
way Ross described and do not know which patients are the
ideal candidates for this operation. We have learned that it is
not appropriate for young patients with rheumatic heart valve
disease and that the autograft may dilate if used for aortic root
replacement in patients with congenital aortic valve disease.
There is yet much more to be learned about this operation!
Tirone E. David, MD
Toronto, Ontario, Canada
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